NCT03043547 Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies Status COMPLETED Phase PHASE2
NCT03000374 Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery Status COMPLETED Phase PHASE2
NCT02997228 Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02959541 PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer Status UNKNOWN Phase NA
NCT02935764 FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients Status UNKNOWN Phase PHASE3
NCT02921256 Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT02872116 Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer Status COMPLETED Phase PHASE3
NCT02856867 Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) Status WITHDRAWN Phase PHASE2
NCT02828358 Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Status COMPLETED Phase PHASE2
NCT02785068 Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02753127 A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT02735239 Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02715531 A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT02676323 Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome Status TERMINATED Phase PHASE1
NCT02641691 Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Status COMPLETED Phase PHASE2
NCT02625610 Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) Status COMPLETED Phase PHASE3
NCT02624726 Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment Status UNKNOWN Phase PHASE2
NCT02620423 Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02578368 Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction Status COMPLETED Phase PHASE3
NCT02551991 Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2